Showing results (1-10 of 964) with videos related to
Sort By:
Pageof 97
Cancer Chemotherapy and Pharmacology|January 1, 1983
Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934)P Dombernowsky, B Lund, H H HansenGynecologic Oncology|July 1, 1997
Phase II trial of high-dose cisplatin plus ifosfamide as first-line followed by carboplatin as second-line treatment in epithelial ovarian carcinomaG Strauss, B Lund, M Hansen, et al.European Journal of Cancer & Clinical Oncology|July 1, 1987
Phase II study of 1,2,4-triglycidylurazol (TGU) in previously untreated and treated patients with small cell lung cancerB Lund, F Hansen, M Hansen, et al.European Journal of Cancer & Clinical Oncology|November 1, 1982
cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II studyB Lund, K Aabo, M Rørth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual diseaseB Lund, M Hansen, O P Hansen, et al.Seminars in Oncology|February 1, 1992
Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancerB Lund, O P Hansen, H H Hansen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual diseaseB Lund, M Hansen, O P Hansen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II studyH Anderson, B Lund, F Bach, et al.Pageof 97